Completed PHASE3 INTERVENTIONAL 2-arm NCT00958880

Yohimbine to Enhance Cognitive Behavioral Therapy (CBT) for Social Anxiety

Placebo-Controlled Evaluation of the Efficacy of Yohimbine Hydrochloride for Enhancing the Effects of CBT for Social Phobia

Sponsor: Southern Methodist University

Conditions Social Anxiety Disorder

Interventions Group Cognitive Behavioral Therapy Sugar Pill Yohimbine Hydrochloride

Updated 5 times since 2017 Last updated: Sep 6, 2013 Started: Mar 31, 2009 Primary completion: Jan 31, 2013 Completion: Jan 31, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00958880, this PHASE3 trial focuses on Social Anxiety Disorder and remains completed. Sponsored by Southern Methodist University, it has been updated 5 times since 2009, reflecting limited change activity. Mental health research at this phase helps define safety and dosing parameters for future study.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3
Jan 2017 — Jun 2018 [monthly]

Completed PHASE3

First recorded

Mar 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Southern Methodist University

Data source: Southern Methodist University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Boston, United States
• Dallas, United States